Michael Thier, MD
Ophthalmology · San Francisco, CANPI 1831295427
Payments from drug & device makers
Across 11 payments — averaging $21.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$74
- Harrow Eye, LLC$35
- Bausch & Lomb Americas Inc.$34
- Oyster Point Pharma, Inc.$25
- Sun Pharmaceutical Industries Inc.$21
- Bausch & Lomb, A Division Of Bausch Health US, LLC$20
- plus $32 from 2 others
What the payments were for
- Food & beverage$22292%
- Gifts$198%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 3 | $74 |
| Harrow Eye, LLC | 1 | $35 |
| Bausch & Lomb Americas Inc. | 2 | $34 |
| Oyster Point Pharma, Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$242 in reported general payments places this provider in the 20th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 32 | $573 |
| Latanoprost | 26 | $208 |
| ErythromycinErythromycin Base | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in San Francisco
- Nisha AcharyaSan Francisco$33M
- Daniel SchwartzSan Francisco$8M
- Robert BhisitkulSan Francisco$778K
- Gaurav ShahSan Francisco$620K
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Raymond DouglasBeverly Hills$9.7M
- Sherif El HaraziGlendale$9.2M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.